Medicure Inc. (CVE:MPH – Get Free Report) shares hit a new 52-week low on Tuesday . The stock traded as low as C$0.88 and last traded at C$0.88, with a volume of 3500 shares trading hands. The stock had previously closed at C$0.91.
Medicure Trading Down 3.3 %
The company’s 50 day moving average price is C$0.98 and its 200 day moving average price is C$1.04. The company has a market cap of C$9.19 million, a price-to-earnings ratio of -3.52 and a beta of 0.90. The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.29 and a current ratio of 1.87.
Medicure (CVE:MPH – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported C($0.12) EPS for the quarter. Medicure had a negative net margin of 12.56% and a negative return on equity of 12.90%. The company had revenue of C$5.17 million for the quarter. Research analysts anticipate that Medicure Inc. will post 0.0652819 EPS for the current year.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- High Flyers: 3 Natural Gas Stocks for March 2022
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- 10 Best Airline Stocks to Buy
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
